RecruitingType 1 Diabetes
Lipoprotein Kinetics in T1D
Eligible age
18–45 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this research study is to understand how type 1 diabetes (T1D) increases the risk for cardiovascular diseases (heart attack and stroke). To this end, the investigators will compare apolipoprotein and triglyceride kinetics in people wtih T1D and healthy control participants.
Sponsor: University of Missouri-Columbia
You may qualify if…
- ✓ Age: ≥18 but ≤45 years
- ✓ premenopausal/eumenorrheic and not pregnant or breastfeeding
- ✓ non-obese (body mass index ≥18.5\<30.0 kg/m2)
- ✓ Fasting plasma triglyceride \<150 mg/dL
- ✓ Additional inclusion criteria for control subjects:
- ✓ Fasting plasma glucose \<100 mg/dL
- ✓ Plasma glucose 2 h after a 75 g oral glucose challenge \<140 mg/dL
- ✓ HbA1c \<5.6%.
You may not qualify if…
- ✕ more than 1.5 h of structured exercise/week
- ✕ use of tobacco products, excessive amounts of alcohol, or dietary supplements and/or medications known to affect lipid metabolism
- ✕ hypothyroidism or other disorders known to affect lipid metabolism
- ✕ conditions that would make it impossible to complete the study protocol
Where it's recruiting
Missouri
Columbia
Source: ClinicalTrials.gov · NCT05179954 · last updated 2026-02-10